AC
WST icon

AXQ Capital’s West Pharmaceutical WST Stock Holding History

AXQ Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-951
Closed -$285K – 645
2024
Q3 		$285K Sell
951
-5,437
-85% -$1.67M 0.09% 348
2024
Q2 		$2.1M Buy
+6,388
New +$2.26M 0.49% 44
2024
Q1 		– Sell
-4,700
Closed -$1.65M – 904
2023
Q4 		$1.65M Buy
4,700
+1,702
+57% +$602K 0.44% 33
2023
Q3 		$1.12M Buy
+2,998
New +$1.16M 0.4% 70
2023
Q2 		– Sell
-4,824
Closed -$1.67M – 601
2023
Q1 		$1.67M Buy
+4,824
New +$1.41M 0.66% 21

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

AXQ Capital's WST Position: Q4 2024 in Review

AXQ Capital sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 951 shares — an estimated $285K sold.

AXQ Capital first reported a position in WST in Q1 2023 and held it in 5 quarters. The position peaked at $2.1M in Q2 2024. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • AXQ Capital reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • AXQ Capital sold 951 West Pharmaceutical shares in Q4 2024, an estimated $285K.
  • AXQ Capital first reported a position in West Pharmaceutical in Q1 2023 and held it in 5 quarters.
  • AXQ Capital's West Pharmaceutical position peaked at $2.1M in Q2 2024.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on AXQ Capital's 13F filing for Q4 2024, filed 11 Feb 2025.